Cite
HARVARD Citation
Tsuda, H. et al. (2002). The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer. International journal of gynecological cancer. 12 (5), pp. 435-437. [Online].